FDA has approved an NDA for LoSeasonique, an oral contraceptive manufactured by Duramed, a subsidiary of Barr Pharmaceuticals.
Eli Lilly & Co. has announced the introduction of a color differentiation system for U-100 insulin products marketed in the US, including vials, pens and individual packaging for Humalog and Humulin.
